BACKGROUND The management of esophageal cancer is challenging and highly complex.
Different treatment modalities have evolved over the years, ranging from endoscopic …

Introduction Esophageal cancer remains a challenging clinical problem, with overall long-
term survivorship consistently at a level of approximately 30%. The incidence of esophageal …

Survival of esophageal cancer is improving but remains poor. Esophageal cancer stage is
based on depth of tumor invasion, involvement of regional lymph nodes, and the presence …

Squamous cell carcinoma (SCC) and adenocarcinoma account for over 95 percent of
esophageal malignant tumors. For most of the 20 th century, SCC predominated. In the …

Most benign and malignant neoplasms of the esophagus are epithelial in origin.
Esophageal carcinomas typically show either glandular or squamous differentiation and …

Esophageal cancer is a relatively uncommon malignancy in the United States, although its
incidence has been increasing since the 1980s. It currently ranks seventh in terms of …

Esophageal cancer is the sixth leading cause of cancer related mortality worldwide, with a 5-
year survival rate of approximately 20%. 1, 2 There are 2 main histologic subtypes …

Previous staging of esophageal cancer was based on a simple, orderly arrangement of
increasing anatomic T, then N, then M classifications. This system is consistent with neither …

Esophageal cancer is a leading cause of cancer-related deaths worldwide, and the 5-year
relative survival rate remains less than 20% in the United States. The treatment of …

Esophageal cancer is a serious malignancy with regards to mortality and prognosis. It is a
growing health concern that is expected to increase in incidence over the next 10 years …